Glucagon-like peptide-1 analogue, liraglutide, delays onset and reduces severity of experimental autoimmune encephalitis in Lewis rats

• Glavni autori: Brian DellaValle (Autor), Gitte Brix (Autor), Birgitte Brock (Autor), Michael Gejl (Autor), Anne Landau (Autor), Arne Møller (Autor), Jørgen Rungby (Autor), Agnete Larsen (Autor)
• Format: Knjiga
• Izdano: Frontiers Media S.A., 2016-11-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

AbstractIntroduction: Recent findings indicate that metabolic disturbances are involved in multiple sclerosis (MS) pathology and influence the susceptibility to treatment, directing attention towards anti-diabetic drugs such as metformin and pioglitazone. Liraglutide, a drug of the glucagon-like pep...